The Somatic Cell Genome Editing (SCGE) Consortium is an NIH Common Fund program that aims to develop safe and effective methods to perform gene editing to treat genetic diseases in somatic cells. For Phase 2, the goal of the SCGE program is to accelerate the development of genome editing therapies into clinic. Learn more about the SCGE at https://scge.mcw.edu/